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Immunodeficient patients whose gut is chronically infected by vaccine-derived poliovirus (VDPV) may excrete large amounts of virus for
years. To investigate how poliovirus (PV) establishes chronic infections in the gut, we tested whether it is possible to establish persistent
VDPV infections in human intestinal Caco-2 cells. Four type 3 VDPV mutants, representative of the viral evolution in the gut of a
hypogammaglobulinemic patient over almost 2 years [J. Virol. 74 (2000) 3001], were used to infect both undifferentiated, dividing cells, and
differentiated, polarized enterocytes. AVDPV mutant excreted 36 days postvaccination by the patient was lytic in both types of intestinal cell
cultures, like the parental Sabin 3 (S3) strain. In contrast, three VDPVs excreted 136, 442, and 637 days postvaccination, established
persistent infections both in undifferentiated cells and in enterocytes. Thus, viral determinants selected between day 36 and 136 conferred on
VDPV mutants the capacity to infect intestinal cells persistently. The percentage of persistently VDPV-infected cultures was higher in
enterocytes than in undifferentiated cells, implicating cellular determinants involved in the differentiation of enterocytes in persistent VDPV
infections. The establishment of persistent infections in enterocytes was not due to poor replication of VDPVs in these cells, but was
associated with reduced viral adsorption to the cell surface.
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Poliovirus (PV) is an enterovirus that causes paralytic
poliomyelitis (Landsteiner and Popper, 1909; Levaditi,
1913). The PV genome, a single-stranded RNA molecule
of positive polarity, is protected by an icosahedral capsid
composed of 60 copies of polypeptides VP1 to VP4
(Rossmann, 2002). The cellular receptor common to all
three PV serotypes is CD155, a glycoprotein member of the
immunoglobulin superfamily (Koike et al., 1990; Mendel-
sohn et al., 1989). At the surface of susceptible cells,
CD155 binds the virus and induces conformational transi-
tions of the capsid that lead to viral uncoating at physio-
logical temperature (Hogle and Racaniello, 2002). During0042-6822/$ - see front matter D 2003 Elsevier Inc. All rights reserved.
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E-mail address: fcolbere@pasteur.fr (F. Colbe`re-Garapin).these transitions, virions sedimenting at 160S externalize
VP4 and the N-terminal part of VP1, thereby forming A
particles sedimenting at 135S. Some A particles are released
from cells at 37jC, while others remain cell-associated. The
production of empty capsids sedimenting at 80S is believed
to result from viral uncoating. CD155 is a major determi-
nant of PV tissue tropism and it is present at the surface of
human neurons (Gromeier and Nomoto, 2002; Pavio et al.,
1996). It is also present at the surface of human polarized
enterocytes and microfold (M) cells, both on the apical face
and more abundantly on the basolateral face (Iwasaki et al.,
2002).
Poliomyelitis is efficiently prevented by either of two
vaccines: the inactivated polio vaccine and the attenuated
oral polio vaccine (OPV) (Minor and Almond, 2002). The
three Sabin strains of the OPV multiply to high titers in the
human intestine, but normally do not invade the central
nervous system. This vaccine is very safe. However, in
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cies, Sabin PV strains of each of the three serotypes can
continue replicating for long periods, more than 10 years,
sometimes causing chronic poliomyelitis (Bellmunt et al.,
1999; Buttinelli et al., 2003; Kew et al., 1998; Minor, 2001;
Yoneyama et al., 2001). Prolonged virus multiplication in
the intestine of patients causes long-term excretion of
neurovirulent vaccine-derived poliovirus (VDPV) in the
stools. Recently, Martin et al. (2000) characterized Sabin 3
(S3)-derived PV isolates, which were excreted by a hypo-
gammaglobulinemic patient over a period of 637 days
postvaccination. Virus excretion appeared to cease sponta-
neously after this period. The isolates followed a main
lineage of evolution, with a rate (2.78% per year) of
nucleotide substitution at synonymous third-base codon
positions that was very similar to that estimated for wild-
type PV during person-to-person transmission (Kew et al.,
1995). Some mutations in the isolates are in regions of the
capsid possibly involved in adaptation for growth in the
human gut and virus persistence (Martin et al., 2000).
PV persistence has never been studied in intestinal cells,
although it has been studied in various cell culture models,
including neuronal and epidermoid cells. The molecular
mechanisms of PV persistence vary greatly between differ-
ent cell types, but modification of either CD155 expression
or of PV–CD155 interactions is common to many persistent
PV infections (Duncan and Colbe`re-Garapin, 1999; Duncan
et al., 1998; Pelletier et al., 1998a). CD155 expression is
reduced in cervix carcinoma HeLa cells (Kaplan and Raca-
niello, 1991) and in some clones of larynx carcinoma HEp-
2c cells (Calvez et al., 1995) following persistent PV
infection. In addition, PV mutants (PVpi) selected during
persistent infection of neuroblastoma IMR-32 cells harbor
capsid mutations in regions interacting with CD155 (Pellet-
ier et al., 1998b). The kinetics of adsorption of PVpi onto
CD155-expressing cells and of elution, and the conforma-
tional modification of the capsid induced by CD155 at
37jC, are often different from those of the parental lytic
PV strains (Duncan and Colbe`re-Garapin, 1999). We have
recently shown that 147S forms are produced upon interac-
tion of particular PV mutants with either CD155-expressing
cells or the soluble receptor PVR–IgG2a at 0jC (Duncan et
al., 1998; Pelletier et al., 2003). These 147S forms have the
same composition as the virion and may be a conforma-
tional intermediate between 160S virions and 135S A
particles (Pelletier et al., 2003).
To develop a cell culture model relevant to chronic PV
infection of the human intestine, we studied PV persistence
in Caco-2 cells, derived from a human colon adenocarcino-
ma. Caco-2 cells grown on permeable filters express genes
that are specifically expressed in villus absorptive enter-
ocytes of the small intestine (Hidalgo et al., 1989; Pinto et
al., 1983; Van Beers et al., 1995). Therefore, despite their
colonic origin, Caco-2 cells differentiate into small intestine
enterocyte-like cells (Costa de Beauregard et al., 1995; Pinto
et al., 1983). We show here that several of the PV mutantsexcreted by an immunodeficient patient can establish per-
sistent infection in human intestinal cells, and that there is a
correlation between this capacity and reduced adsorption
kinetics onto cells.Results
Characterization of the intestinal cell culture models
To study the capacity of VDPV mutants to establish
persistent infections in undifferentiated dividing intestinal
cells and in polarized enterocyte-like cells, we first charac-
terized our intestinal cell culture models. Caco-2 cells were
seeded onto Transwell filters as described in Materials and
methods. The interactions of PV with CD155 are generally
involved in persistent PV infections; therefore, we tested for
CD155 expression at the cell surface by indirect immuno-
fluorescence with a monoclonal antibody specific for
CD155 and secondary antibodies labeled with fluorescein
isothiocyanate (FITC). As previously shown (Tucker et al.,
1993a), CD155 was present on both faces of the Caco-2
cells and was more abundant on the basal face of both 3-
and 14-day-old cultures (Fig. 1). Two- to four-day-old
Caco-2 cells were used to study VDPV–CD155 interactions
(see below). We verified that the average expression of
CD155 at the cell surface was constant over this time by
immunofluorescence and analysis with a fluorescence-acti-
vated cell sorter (not shown). The structural protein F-actin
that is associated with the cytoskeleton and present in the
microvilli of the brush border of polarized enterocytes was
detected by its specific binding to phalloı¨din-alexa. F-actin
was principally expressed at the basal face of 3-day-old
Caco-2 cells (Fig. 1M). In contrast, it was principally
expressed on the apical face of 14-day-old cells, consistent
with the presence of F-actin in brush border microvilli of
14-day-old Caco-2 cells (Fig. 1N). The presence of the
brush border on the apical face of 14-day-old Caco-2 cells
was confirmed by labeling terminal fucose residues of the
brush border glycocalyx with the lectin UEA1 conjugated to
FITC, and by transmission electron microscopy (data not
shown), as previously shown for enterocyte-like cells
obtained by differentiation of a clone of Caco-2 cells
(Ouzilou et al., 2002). The trans-epithelial resistance in-
creased from about 400 to 750 Vcm2 between days 3 and
14 of culture, indicating that 14-day-old cells formed tight
monolayers, due to the presence of tight junctions. Thus, 14-
day-old Caco-2 cells acquired characters of polarized enter-
ocytes, in particular cell polarity, a brush border and tight
junctions.
Persistent poliovirus infection in Caco-2 cells
Seven isolates of type 3 VDPVs obtained from a hypo-
gammaglobulinemic patient, chronically infected by Sabin
3-derived PV mutants over almost 2 years until the patient
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previously (Martin et al., 2000). The number in the name of
isolates (H36, H136, H307, H391, H442, H480, and H637)
indicates the day postvaccination when the virus was
collected. The virus excreted by the patient on any 1 daycould have been a mixture, and thus clones were obtained
by plaque purification twice and named H36-11 to H637-11.
The genomic region encoding capsid proteins, which har-
bors all the determinants required to confer to PV a
persistent phenotype in HEp-2c cells (Calvez et al., 1993;
Fig. 2. Persistent poliovirus infection in Caco-2 cell cultures. Confluent 4- or 5-day-old Caco-2 cells were infected at an MOI of 10 4 ID50/cell with the Sabin 3
strain (S3), the mutant PVpi L2-2, and the four VDPV clones, H36-11 to H637-11. The results are expressed as the percentage of persistently infected cultures
2 months postinfection. The mean of three experiments is presented, and the horizontal error scale bars represent the SEM.
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clones. This genomic region in four of the clones (H36-11,
H136-11, H442-11, and H637-11) contained no missense
mutations with reference to the consensus sequence of the
corresponding isolates. It thus seems probable that these
viral clones correspond to the major virus populations in the
respective isolates. These four clones correspond to the first
and last isolates, and to two intermediate isolates, and
therefore cover the entire period of the evolution of the
VDPVs. The three other clones had either a supplementary
mutation (VP130 Ala >Val in H307-11, and VP379 Ser >
Met in H480-11) or lacked one missense mutation (at
residue VP134 in H391-11). Other clones of the same
isolates also differed from the respective consensus sequen-
ces. These clones may be quasi-species. Therefore, only
VDPV clones H36-11, H136-11, H442-11, and H637-11
were included in all experiments.
The capacity of the four viral clones, H36-11, H136-11,
H442-11, and H637-11, to establish persistent infectionsFig. 1. Immunofluorescence analysis of CD155 expression in 3-day-old Caco-2
Transwell filters for 3 days (left-hand panels) or 14 days (right-hand panels). Fluor
cells. The Bl and Ap planes of 3-day-old Caco-2 cells are designated by reference
receptor (PVR or CD155) was detected with the monoclonal antibody 404 (Lopez e
visualize Caco-2 cell differentiation, F-actin was stained with phalloı¨din-alexa (
Images were captured by confocal microscopy through a 63 objective lens. Panel
(FITC) and red (alexa) channels, from Bl to Ap planes of 3- and 14-day-old C
fluorescence intensity for three separate fields in the same plane. Vertical scale bar
and 14-day-old cultures, respectively. The distance between two planes is 1 Am a
MetaMorph Offline (Universal Imaging, version 4.6 r0).was tested in undifferentiated, 4- to 5-day-old Caco-2 cells,
using as controls the parental Sabin 3 strain, which is lytic in
HEp-2c cells, and a type 3 PVpi, L2-2, which establishes
persistent infections in 100% of HEp-2c cell cultures
(Duncan et al., 1998). During the first 3 weeks postinfec-
tion, cytopathic effects were detected in all infected Caco-2
cultures, and 1 month postinfection, a few growing cell
colonies appeared in cultures infected with either PVpi L2-2
or one of VDPV H136-11, H442-11, or H637-11. Caco-2
cells persistently infected by VDPV mutants could be grown
for at least 6 months. However, the percentage of persis-
tently infected cultures was determined 2 months postinfec-
tion (Fig. 2). PVpi L2-2 established persistent infections in
47F 12% of Caco-2 cell cultures. The Sabin 3 strain and
viral clone H36-11—the first isolate—were entirely lytic
(Fig. 2). H136-11, H442-11, and H637-11 established
persistent infections in 8–17% of cultures (Fig. 2). Thus,
only three of four VDPVs were persistent, implicating viral
determinants in the establishment of persistent infections incells and polarized enterocytes. Caco-2 cells were seeded and cultured on
escence is shown both on basolateral (Bl) and apical (Ap) planes of Caco-2
to differentiated enterocytes (the basal face is adjacent to the filter). The PV
t al., 1997) and anti-mouse immunoglobulin conjugated to FITC (A–D). To
E–H). Simultaneous detection of CD155 and F-actin is presented (I–L).
s M and N show fluorescence intensity profiles (in arbitrary units) for green
aco-2 cells, respectively. Each value in M and N represents the average
s indicate the standard errors of the means (SEM) for 18 and 21 planes of 3-
nd the thickness of each slide is 0.3 Am. Fluorescence was quantified with
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dominant) in the patient after day 36 and were present in
VDPVs from days 136 to 637 postvaccination.
In HEp-2c cells, H36-11 was lytic and H136-11, H442-
11, and H637-11 mutants established persistent infections in
61F16%, 17F 10%, and 69F 16% of HEp-2c cell cul-
tures, respectively. Therefore, each VDPV mutant was
either lytic or persistent in both HEp-2c and Caco-2 cell
lines.
Interestingly, 20–80% of Caco-2 cell cultures persistent-
ly infected by the VDPV mutants stopped excreting infec-
tious virus between 1 month and 1 year postinfection.
Persistent poliovirus infection in polarized enterocyte-like
cells
We investigated whether differentiation of Caco-2 cells
affects the establishment of persistent infections. Caco-2 cell
cultures were grown for 2 weeks on microporous mem-
branes until they were differentiated into polarized enter-
ocyte-like cells, and then they were infected with H36-11,
H136-11, H442-11, H637-11, the parental S3 strain, and
PVpi L2-2. Although the level of CD155 expression is
higher on the basolateral than on the apical face of cells, the
level on the apical face is sufficient to mediate efficient
infection (Tucker et al., 1993a); therefore, cells were
infected either by the apical or by the basolateral faceFig. 3. Persistent poliovirus infection in polarized enterocyte-like cells. Caco-2
differentiation of Caco-2 cells into enterocyte-like cells. Cells were then infected at
four VDPV clones, H36-11 to H637-11, either from the apical face (dark gray) or f
were performed with each virus, and the percentage of persistently infected culture(Fig. 3). Five days postinfection, apical and basolateral
supernatants were collected and the virus titered: all cultures
excreted virus, and the titers were above 105 infectious
doses 50 (ID50)/ml in the apical chamber. Cytopathic effects
were detected in all infected cultures. The percentage of
persistently infected cultures was determined 4 weeks post-
infection because the filters were not appropriate to grow
enterocyte-like cells for longer periods. The parental S3
strain and H36-11 were lytic, as in undifferentiated Caco-2
cells. PVpi L2-2 established persistent infections in more
than 65% of infected cultures, and the clones H136-11,
H442-11, and H637-11 in more than 75% of infected
cultures, independently of the face of cells used for virus
inoculation (Fig. 3). The percentage of persistently VDPV-
infected cultures was higher in enterocyte-like cells than in
4- to 5-day-old Caco-2 cell cultures, 1 and 2 months
postinfection, suggesting that cellular determinants involved
in the differentiation of enterocytes also contribute to the
establishment of persistent infections by the VDPV mutants.
No spontaneous cure was observed in VDPV-infected enter-
ocyte-like cells, even when these cells could be maintained
for periods longer than 1 month.
One-step virus growth cycles in polarized enterocytes
We tested whether multiplication of the persistent VDPV
mutants (H136-11, H442-11, H637-11) was impaired incells seeded on Transwell filters were grown for 14 days to induce the
an MOI of 10 4 ID50/cell with the Sabin 3 strain (S3), the PVpi L2-2, or the
rom the basolateral face (light gray). At least three independent experiments
s 1 month postinfection is presented with SEM (horizontal error scale bars).
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ments were performed at a multiplicity of infection (MOI)
of 10 ID50/cell with two of the persistent mutants (H136-11
and H442-11) and with the parental lytic S3 strain. No
significant difference was observed between the multiplica-
tion of the persistent VDPVs and that of the S3 strain: the
exponential growth and the intracellular yields were com-
parable for the three viruses. Intracellular yields were high
(about 109 ID50/ml and per culture of 1.5 106 cells) (Fig.
4, upper panel). Virus liberation was also similar for all three
viruses, and about 1000-fold more efficient from the apical
face than from the basolateral face of cells, 48 h postinfec-
tion (Fig. 4, lower panel), in agreement with the results
previously published for the Mahoney PV strain (Tucker et
al., 1993b).Fig. 4. One-step virus growth cycles in polarized enterocytes. Caco-2 cells were see
at an MOI of 10 ID50/cell with the lytic strain S3 and the persistent VDPV clone
apical or basolateral virus (lower panel) were titered on Caco-2 cells. Averages of f
are indicated by vertical scale bars (they are barely visible because of the log scaReduced adsorption of the persistent VDPVs onto Caco-2
cells
There are numerous mutations in the capsid proteins of
the persistent VDPVs: some in the canyon (VP2139,
VP2140), in or near antigenic site 3a (VP1288), site 4
(VP379, VP3116), or at the interface of protomers (VP391)
(Martin et al., 2000). These residues may affect binding of
VDPVs to CD155 and the plasticity of the viral capsid,
respectively. Therefore, the early steps of the viral cycle
were studied in Caco-2 cells for the three persistent VDPVs,
the lytic VDPV H36-11 and the lytic S3 strain. The
adsorption of H36-11 was more efficient than that of S3
(Fig. 5A), and similar to that of the wild-type strain T7/Leon
used as an internal control (not shown). In contrast, the three
y 318 (2004) 66–78 71ded on Transwell filters and were infected 2 weeks later from the apical side
s, H136-11 and H442-11. Intracellular virus (upper panel) and extracellular
our cultures from two independent experiments are presented, and the SEM
le).
Fig. 5. Analysis of virus adsorption (panel A) and particle elution (panel B) at the surface of Caco-2 cells for the lytic strain S3, the lytic VDPV clone H36-11,
and the three persistent VDPV clones, H136-11, H442-11, and H637-11. (A) Caco-2 cells in suspension were infected with radiolabeled virions at 0jC for the
times indicated. The cell-associated radioactivity was counted and is expressed as the percentage of the radioactivity present in the inoculums. (B) Caco-2 cells
were infected in suspension. After 2.5 h of adsorption, unattached virus was removed and cells were incubated at 37jC for the times indicated. The cell-
associated radioactivity was measured and is expressed as a percentage of the radioactivity present before the 37jC incubation period. For both the adsorption
and elution experiments, each point represents the mean value of three independent experiments, and the SEM are indicated by vertical scale bars.
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Caco-2 cells (Fig. 5A). VDPVs H442-11 and H637-11,
excreted late, had the lowest binding efficiency, about half
that of S3. Thus, reduced adsorption correlated with the
persistent phenotype of mutants H136-11, H442-11, and
H637-11.
Virus elution and conformational transitions of the capsid
Increased elution or modified conformational transitions
may contribute to the mechanism of the persistent infection,
as previously shown for PVpi in HEp-2c cells (Duncan etal., 1998; Pelletier et al., 1998a). Therefore, these steps
were studied, and to compare the proportion of eluted
particles regardless of the number of attached virions,
values are expressed as a percentage of the total cell-
associated radioactivity (Fig. 5B). The H442-11 and
H637-11 viruses eluted from cells at 37jC faster and more
efficiently than the lytic VDPV H36-11 and the S3 strain.
The enhanced elution of H442-11 and H637-11 may thus
contribute to the persistent phenotype of these viruses.
However, the kinetics of elution of VDPV H136-11 was
similar, and even slightly slower than that of S3. The VDPV
H36-11 had the lowest elution rate (Fig. 5B) and its profile
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strain (not shown).
The uncoating transitions from 160S virions to 135S A
particles were then analyzed by ultracentrifugation in
sucrose gradients. Sedimentation profiles of cell-associated
particles are shown for a 0- or 20-min incubation period at
37jC (Fig. 6). Like S3, all of the mutants sedimented at
160S after binding to Caco-2 cells for 3 h at 0jC, and the
corresponding peak decreased after incubation at 37jC,
leading to the formation of 135S A particles. The alteration
ratio (i.e., the ratio of the area under the 135S peak to the
area under the 160S peak) was between 0.3 and 0.4 for
VDPVs H36-11, H136-11, and H637-11, and 0.5 for the
control strain, S3 (Fig. 6). VDPV H442-11 had an alter-Fig. 6. Capsid conformational transitions from 160S to 135S particles. Caco-2 cell
were washed and incubated for either 0 (continuous line) or 20 min (broken line
capsid. Cells were then lysed and viral particles were separated by sucrose gradient
and fractions were counted for radioactivity. The 135S/160S alteration ratio is pration ratio almost twice as high as that of S3, and after 20
min, the uncoating process of this VDPV appeared more
complete than that of the other viruses tested. Thus, the
extent of the uncoating transitions in 20 min did not
correlate with the capacity of the VDPVs to establish
persistent infections.Discussion
Immunodeficient patients whose gut is chronically
infected by VDPVs can excrete large amounts of virus for
years. Unfortunately, there is no convenient small animal
model to investigate how PV establishes chronic infectionss in suspension were infected with radiolabeled virions for 3 h at 0jC. Cells
) at 37jC to permit CD155-induced conformational transitions in the viral
(15–30%) centrifugation. The gradients were fractionated from the bottom,
esented for each virus.
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establish persistent PV infections in vitro in human intestinal
cells. The expression of CD155 was first verified at the
surface of Caco-2 cell-derived enterocytes, and the differ-
entiation of cells was monitored by examining the distribu-
tion of F-actin in the cells. In addition, the formation of a
typical brush border was observed by transmission electron
microscopy, and the presence of fucose residues in the
glycocalyx was verified.
We have previously shown that the P1 region of PV type
3, the region that encodes the capsid proteins, harbors the
main determinants involved in the phenotype persistence in
epithelial-like HEp-2c cells (Duncan et al., 1998). In this
study, four sequential VDPV clones excreted by an immu-
nodeficient individual and covering a 637-day period (Mar-
tin et al., 2000) were studied in terms of their ability to
establish persistent infections in intestinal cell cultures.
H36-11, the first isolate from the patient, was, like the
parental S3 strain, lytic in dividing 4- to 5-day-old Caco-2
cultures. Interestingly, H136-11 and two other mutants
isolated later (H442-11 and H637-11) established persistent
infections in 8–17% of Caco-2 cell cultures. The same
VDPVs established persistent infections in HEp-2c cells.
Thus, viral mutations acquired or selected between 36 and
136 days postvaccination were responsible for the pheno-
type of persistence. Seven capsid residues in VP1 and VP2
differentiate H136-11, which is persistent, from H36-11 that
is lytic (Table 1). They include mutations at residues VP214
and VP1288 close to residues VP213 and VP1290, respec-
tively, involved in the capacity of a type 3 PVpi to establish
persistent infections in HEp-2c cells (Duncan et al., 1998).
Therefore, residues VP214 and VP1288 may contribute to the
capacity of H136-11, H442-11, and H637-11 to establish
persistent infections in Caco-2 (and HEp-2c) cells. Howev-Table 1
Nucleotide position and amino acid differences between the lytic and persistent s
Genome Nucleotide Amino acid Amino acid in
region position position
S3
VP2 989 14 Leu
1176 76 Lys
1366 139 Gln
1368 140 Arg
1413 155 Lys
1451 168 Ser
1458 170 Lys
1505 186 Leu
VP3 1997 79 Ser
2034 91 Phe
2108 116 Phe
2387 209 Ser
VP1 2510 12 Gly
2577 34 Ala
3242 256 Val
3299 275 Ala
3338 288 Asn
Amino acid residues that differentiate lytic and persistent VDPV strains, and areer, this remains to be confirmed, and the involvement of the
other mutations cannot be excluded.
Viral determinants play a major role in the establish-
ment of persistent infections both in Caco-2 and in HEp-2c
cells. Spontaneous cures occurred in persistently VDPV-
infected Caco-2 cells, as previously observed in persistent-
ly PVpi-infected HEp-2c cells (Calvez et al., 1995).
Therefore, persistent infections in Caco-2 and HEp-2c cells
seem to have several common features that differ from
those in cultured neuronal cells, in which viral determi-
nants do not play the major role and in which no
spontaneous cure has ever been observed (Colbe`re-Garapin
et al., 2002).
VDPV mutants H136-11, H442-11, and H637-11 estab-
lished persistent infections in enterocyte-like cells as they
did in young Caco-2 cell cultures, but with a higher
frequency, that is, in more than 75% of cultures. This
suggests that the same viral determinants play a role in
the establishment of persistent infections in both types of
intestinal cell cultures, but that cellular determinants in-
volved in the differentiation of enterocytes also contributed
to persistence. No spontaneous cure was observed in
VDPV-infected enterocytes, possibly because these cul-
tures, unlike Caco-2 cells, could not be maintained for
several months. Alternatively, the absence of cure in
VDPV-infected enterocytes suggests either that cell division
plays a role in the spontaneous cure of Caco-2 cells, or that
the expression of cellular genes involved in enterocyte
differentiation is not favorable to the cure of cells. If the
absence of spontaneous cure in enterocyte-like cells is
relevant to infection of fully differentiated enterocytes in
patients, it is probable that these cells are normally elimi-
nated in vivo when they are replaced by newly differenti-
ated enterocytes.trains of VDPV in the capsid region
lytic strain Amino acid in persistent strain
H36-11 H136-11 H442-11 H637-11
– Met Met Met
– Ile – –
– – His His
– Met Met Met
– – Ile –
– Pro – –
– – – Arg
Met Met Met Met
– – Thr Thr
Ser Ser Ser Ser
– – Leu Leu
– – – Cys
– – Ser –
– Val Val Val
– – – Ile
Thr Ser Thr Thr
– Asp Asp Asp
common to the three persistent VDPV strains, are underlined.
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tence. The restriction of PV replication sometimes contrib-
utes to the mechanism of PV persistence (Borzakian et al.,
1992; Calvez et al., 1995; Girard et al., 2002). However, the
establishment of persistent infections in enterocyte-like
cells was not due to poor replication of VDPVs in these
cells: one-step growth cycles were similar for the lytic S3
strain and the persistent VDPVs H136-11 and H442-11,
with high intracellular yields and efficient, polarized virus
liberation by the apical face. The early steps of PVpi
multiplication are generally modified in HEp-2c cells
(Duncan et al., 1998; Pelletier et al., 1998a), and conse-
quently, we studied adsorption, elution, and uncoating
transitions of VDPVs. The mutant H36-11, like T7/Leon
(not shown), had an adsorption rate significantly higher
than that of S3 (Fig. 5A). This may be related either to the
reversion in H36-11 of an attenuating determinant, at
residue VP391, toward the T7/Leon genotype, or to H36-
11 residues VP2186 Met and VP1275 Thr (Table 1), the latter
residue being close to the footprint of CD155 on the PV3
capsid (He et al., 2003). Interestingly, the adsorption rates
of persistent VDPVs (H136-11, H442-11, and H637-11)
were lower than those of the lytic strains (S3 and H36-11).
The high elution rate of H442-11 and H637-11 may
contribute to the phenotype of persistence of these viruses,
as previously reported for a type 1 PVpi (Pelletier et al.,
1998a). However, the elution rate of H136-11 was slightly
slower than that of S3, and yet, H136-11 established
persistent infections efficiently in enterocyte-like cells. As
for elution, there was no strict correlation between the
efficiency of uncoating transitions and the capacity of
VDPVs to establish persistent infections. No 147S particle
was detected following adsorption of any of the VDPV
mutants onto Caco-2 cells, confirming that there is no strict
correlation between the formation or accumulation of these
particles and PV persistence (Duncan and Colbe`re-Garapin,
1999; Pelletier et al., 1998b).
Therefore, adsorption was the only early step potentially
involved in the mechanism of persistence of the three
persistent VDPVs in intestinal cell cultures. Although this
reduced adsorption did not prevent a high level of viral
replication, as mentioned above, reduced interactions be-
tween persistent VDPVs and CD155 may correlate with a
low level of apoptosis in infected cells. Indeed, PV induces
apoptosis in Caco-2 cells (Ammendolia et al., 1999), and we
have recently shown that the frequency of PV-induced
apoptosis is reduced when PV–CD155 interactions are
affected by a mutation in the N-terminal domain of
CD155, which interacts with PV (Gosselin et al., 2003).
The establishment of a persistent VDPV infection may also
depend on several viral factors. A mutation in the 3A-
coding region of a PV is associated with reduced Vero cell
lysis following viral multiplication (Lama et al., 1998).
Moreover, our results strongly suggest that cellular factors
involved in the differentiation of enterocytes may contribute
to the establishment of persistent infections in humanintestinal cells. It would be particularly interesting to iden-
tify these factors and discover their role in persistent VDPV
infection.Materials and methods
Cells and viruses
The human colon adenocarcinoma cell line Caco-2
(passages 10 to 40) was grown at 37jC in Dulbecco’s
modified Eagle’s medium (DMEM) with 10% fetal calf
serum (FCS). Enterocyte-like cells were obtained by seed-
ing Caco-2 cells in the upper chamber of polyester Trans-
well-Clear filters (Corning Costar) with pores of 0.4- or 3-
Am diameter, in DMEM supplemented with glucose (1 g/l),
and 1% nonessential amino acids (NEAA) in a humidified
9% CO2 incubator.
We used the vaccinal attenuated P3/Leon 12a1b Sabin
strain (Sabin 3 or S3) and a PV mutant (PVpi), L2-2,
derived from wild-type P3/Leon/37 after 2.5 months of
persistent infection in human neuroblastoma cell line
IMR-32 and persistent in HEp-2c cells (Duncan et al.,
1998). The seven sequential Sabin 3-derived viruses (H36
to H637) were isolated from a hypogammaglobulinemic
patient who had excreted virus for 637 days (Martin et al.,
2000). We cloned each VDPV isolate twice by plaque
purification on HEp-2c cells under an agarose (0.8%)
overlay. All viral stocks were prepared on HEp-2c cells,
and virus infectivity was titered on these cells by an
endpoint micromethod. The infectious titers are expressed
per milliliter as the log10 of the highest dilution for which
cytopathic effects and cell lysis were observed in 50% of
wells 7 days after infection at 37jC. Titers varied between
0.05 and 5 108 ID50/ml. The capsid protein-encoding
region in each viral clone was sequenced.
Viral RNA sequencing
cDNA was synthesized exactly as previously described
(Oprisan et al., 2002) using four antisense primers (C1484,
C2474, C2658, C3586; the number indicating primer
position in viral genome). The synthesized cDNA was then
amplified with 10 pmol genomic primers (G614, G1913,
G2402) and 2.6 U Enzyme mix high fidelity (Roche).
Amplification involved 29 cycles of denaturation at 94jC
for 15 s, annealing at 45jC for 30 s, and elongation at
68jC for 2 min, followed by a final cycle of denaturation at
94jC for 15 s, annealing at 45jC for 30 s, and elongation
at 68jC for 7 min. PCR products were analyzed by
electrophoresis in ethidium bromide-stained 0.8% agarose
gels and then purified using the QIAquick Spin Purification
(Qiagen), according to the manufacturer’s instructions. The
amplified DNA fragments were sequenced using the Big-
Dye Terminator Cycle Sequencing Ready Reaction Kit
(Perkin Elmer Applied Biosystems) on the ABI Prism
K. Labadie et al. / Virolog76DNA 377 Sequencer (Perkin Elmer Applied Biosystems).
Nucleotide sequences were aligned with CLUSTAL W
(Thompson et al., 1994).
Indirect immunofluorescence
Caco-2 cells seeded on Transwell filters for 3 or 14
days were fixed for 15 min at 20jC in 4% paraformalde-
hyde and then treated for 10 min with NH4Cl (50 mM).
Cells were incubated either with the anti-CD155 mono-
clonal antibody 404 (14 Ag/ml) (Lopez et al., 1999) or
with a control immunoglobulin G1 for 60 min at 20jC,
washed twice with phosphate-buffered saline (PBS)–
Ca2+–Mg2+ containing 2% filtered FCS, and then incu-
bated for 60 min with anti-mouse immunoglobulin conju-
gated to FITC (15 Ag/ml). Cells were washed again, then
permeabilized for 2 min with Triton X-100 (0.5%), and
were incubated with phalloı¨din-alexa (0.4 U/ml) for 30
min to stain F-actin. Filters were washed again and
mounted in Vectashield, and cells were viewed under a
Leica confocal microscope with a 63 objective. Fluo-
rescence (green and red channels) from basolateral to
apical face was quantified with MetaMorph Offline (Uni-
versal Imaging, version 4.6 r0).
Establishment of persistent infection in Caco-2 cells
Confluent 4- or 5-day-old Caco-2 cells, cultivated in 24-
well plates, were washed with DMEM and then infected at a
multiplicity of infection (MOI) of about 10 4 ID50/cell.
Infected cells were grown at 37jC in a humidified 4% CO2
incubator, in DMEM-2% FCS for the first week, and then in
DMEM-10% FCS for a minimum of 8 weeks, changing the
medium once per week.
To induce Caco-2 cell differentiation into polarized
enterocyte-like cells, Caco-2 cells were seeded at a density
of 4.104 cells/cm2 on tissue culture-treated polyester Trans-
well filters. Apical and basal media were replaced every 3 or
4 days for 14 days with DMEM-10% FCS until cells
reached confluence, and then with DMEM-2% FCS. Two
weeks after seeding, cells were infected either from the
apical or basolateral side as described above, except that
cells were grown in a humidified 9% CO2 incubator for at
least 1 month.
Single-cycle growth experiments
Enterocyte-like Caco-2 cells were infected, 2 weeks after
seeding on filters by the apical face, at an MOI of 10 ID50/
cell in 200 Al of DMEM for 30 min at 37jC. Cells were
washed three times and then incubated for 2, 4, 6, 12, 24, or
48 h at 37jC in 9% CO2 atmosphere. For each time point,
both apical and basolateral supernatants were collected.
Intracellular virus was recovered by freezing and thawing,
and all samples were clarified before titering virus on Caco-
2 cells.Preparation of radiolabeled virions
Confluent HEp-2c cells were infected at an MOI of about
10 ID50/cell and agitated for 30 min at 37jC. Medium
supplemented with 2% FCS was then added, and cells were
incubated for 2 h at 37jC. The medium was then changed to
methionine- and cysteine-free medium for 30 min, and 600
ACi of 35S-methionine and 35S-cysteine (TRAN35S-LA-
BEL; ICN) were added. Cells were lysed 24–48 h postin-
fection by freezing and thawing. Virus was clarified and
purified from cytoplasmic extracts by CsCl density gradient
centrifugation as previously described (Blondel et al., 1983;
Pelletier et al., 1991). Purified virus was desalted by gel
filtration on a PD-10 column (Pharmacia Biotech) and then
stored at 80jC. As the specific activities of S3, PVpi L2-
2, and VDPV mutants varied between 0.7 and 18 10 4
cpm/ID50, the same MOI (140 or 200 ID50/cell) was used in
experiments with radiolabeled viruses. The results of virus
adsorption and elution are expressed as percentages of cell-
associated radioactivity.
Virus adsorption onto Caco-2 cells
Virus adsorption was studied, as previously described
(Duncan et al., 1998; Pelletier et al., 1998a), using 2- to 4-
day-old Caco-2 cells in suspension on ice. Cells (0.75
106) were infected with radiolabeled virions at an MOI of
140 ID50/cell in 150 Al of DMEM-2% FCS. Infected cells
were agitated on ice for 30, 60, 90, 120, 150, 180, and 210
min after which cells were washed twice with DMEM-2%
FCS and once with PBS. Cell-associated radioactivity was
determined by scintillation counting.
Particle elution from Caco-2 cells at 37jC
Undifferentiated Caco-2 cells (0.75 106) in suspension
were infected, as previously described (Duncan et al., 1998;
Pelletier et al., 1998a), with radiolabeled virions at an MOI
of 140 ID50/cell in 150 Al of ice-cold DMEM-2% FCS.
After 2.5 h of adsorption, infected cells were washed twice
and incubated for various times (0, 15, 30, 60, 90, 120, and
150 min) in 3 ml of DMEM-2% FCS preheated to 37jC.
Cells were then washed once with ice-cold PBS and cell-
associated radioactivity was determined by scintillation
counting.
Capsid conformational transitions
Undifferentiated Caco-2 cells (0.5 107) in suspension
were infected with radiolabeled virions at an MOI of 200
ID50/cell for 3 h at 0jC, and then treated exactly as
previously described (Pelletier et al., 1998a). Briefly,
Caco-2 cells were incubated at 37jC for either 0 or 20
min and lysed. The 20-min time point was chosen because
at this time, about 50% of the capsids of the reference S3
strain were transformed into uncoating intermediates. The
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that were centrifuged in a Kontron TST 41.14 rotor for 2 h at
40000 rpm at 4jC.Acknowledgments
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